...-analysis Biomarker Bladder cancer is one of the most common malignant tumors of the urinary tract with a high incidence worldwide, especially in industrialized countries [ 1, 2 ]. According to global cancer statistics, bladder cancer accounts for more than 500,000 new cases and 200,000 deaths...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2025 SIRT7 Upper tract urothelial carcinoma Adjuvant chemotherapy Immunotherapy Biomarker Upper tract urothelial carcinoma (UTUC) is a relatively rare tumor type, derived...

..., p = 0.0005). Conclusion: Low CCNA2 expression is significantly associated with worse OS. Thus, CCNA2 might serve as a potential biomarker in muscle-invasive UTUC and may be used to characterize a subset of patients having an unfavorable outcome and for future risk assessment scores. Cyclin A2...

...) and progression groups (p = 0.216). Conclusion: For patients with intermediate- and high-risk NMIBC, serum SII levels do not present as an appropriate biomarker for the prediction of disease recurrence and progression following intravesical BCG therapy. A possible explanation for the failure of SII to predict BCG...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2022 [email protected] Numerous molecular biomarkers for bladder cancer diagnosis and surveillance have...

... at 37°C and 5% CO 2 . Long noncoding RNA long intergenic noncoding RNA 00707 miR-145 Bladder cancer Metastasis Biomarker Cell division cycle associated 3 Bladder cancer (BC) ranks the fifth most common cancer type in humans in developed countries and is one of the costliest...

...Klaus-Peter Dieckmann; Finja Hennig; Petra Anheuser; Ralf Gehrckens; Florian Viehweger; Christian Wülfing; Gazanfer Belge Background: MicroRNA-371a-3p (miR-371), the novel serum biomarker of testicular germ cell tumours (GCTs), is produced by undifferentiated subtypes of GCTs but not by teratoma...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Low-molecular-weight protein tyrosine phosphatase Metastatic hormone-naïve prostate cancer Biomarker Androgen...

..., instructions or products referred to in the content or advertisements. Seminoma Testicular neoplasm Biomarker Alpha fetoprotein Germ cell tumour Alpha fetoprotein (AFP) is one of the sentinel serum biomarkers of testicular germ cell tumours (GCTs) [ 1 ]. Physiologically, AFP is synthesised...

...Petra Anheuser; Arlo Radtke; Christian Wülfing; Jennifer Kranz; Gazanfer Belge; Klaus-Peter Dieckmann Introduction: MicroRNA (miR)371a-3p was suggested to be a sensitive and specific new serum biomarker of germ cell tumours (GCTs); however, its clinical usefulness remains unproven. Patients...

...Klaus-Peter Dieckmann; Meike Spiekermann; Thomas Balks; Raphael Ikogho; Petra Anheuser; Werner Wosniok; Thomas Loening; Jörn Bullerdiek; Gazanfer Belge Background: microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell tumors (GCTs), but their specificity is unresolved. We aimed...

... to in the content or advertisements. microRNA miRNA miR-21 PTEN Metformin Renal cell carcinoma Kidney cancer Biomarker Modified cell metabolism is a vital component for cancer cells. MF is an anti-diabetic drug which - besides improving glycaemic control - alters multiple pathways in benign...

... biomarker for predicting clinical outcome of CCRCC. Tissue samples were obtained from 73 patients who underwent radical nephrectomy or partial nephrectomy for renal neoplasm at the Peking Union Medical College Hospital (PUMCH) between August 2006 and November 2008. Postoperative pathology examinations...

..., %fPSA and PSAD. 26 08 2013 7 10 2013 8 4 2014 Prostate cancer Biopsy Biomarker Prostate-specific antigen proPSA Prostate-specific antigen isoform Fig. 1 Box and whiskers plots for each variable. Fig. 1. Box and whiskers plots for each variable. Analyzing...

... is a useful biomarker for monitoring the clinical course for a limited number of RCC patients, but is not a marker for diagnosis and staging. Concentrations of CK-B in RCC tissues were significantly lower than those of normal kidney. A high rate of cell turnover in tumor tissues might entail the higher level...